ABSTRACT
The potential use of induced pluripotent stem cells (iPSCs) in personalized regenerative medicine applications may be augmented by transgenics, including the expression of constitutive cell labels, differentiation reporters, or modulators of disease phenotypes. Thus, there is precedence for reproducible transgene expression amongst iPSC sub-clones with isogenic or diverse genetic backgrounds. Using virus or transposon vectors, transgene integration sites and copy numbers are difficult to control, and nearly impossible to reproduce across multiple cell lines. Moreover, randomly integrated transgenes are often subject to pleiotropic position effects as a consequence of epigenetic changes inherent in differentiation, undermining applications in iPSCs. To address this, we have adapted popular TALEN and CRISPR/Cas9 nuclease technologies in order to introduce transgenes into pre-defined loci and overcome random position effects. AAVS1 is an exemplary locus within the PPP1R12C gene that permits robust expression of CAG promoter-driven transgenes. Gene targeting controls transgene copy number such that reporter expression patterns are reproducible and scalable by â¼2-fold. Furthermore, gene expression is maintained during long-term human iPSC culture and in vitro differentiation along multiple lineages. Here, we outline our AAVS1 targeting protocol using standardized donor vectors and construction methods, as well as provide practical considerations for iPSC culture, drug selection, and genotyping.
Subject(s)
Chromosomes, Human, Pair 19/genetics , Genetic Engineering , Induced Pluripotent Stem Cells/physiology , Base Sequence , CRISPR-Cas Systems , Cell Differentiation , Cell Line , Cloning, Molecular , Dependovirus , Genes, Reporter , Genetic Loci , Genetic Vectors , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Humans , Parvovirinae/genetics , Promoter Regions, Genetic , Transfection , TransgenesABSTRACT
The skin of mammals is a multilayered and multicellular tissue that forms an environmental barrier with key functions in protection, regulation, and sensation. While animal models have long served to study the basic functions of the skin in vivo, new insights are expected from in vitro models of human skin development. Human pluripotent stem cells (PSCs) have proven to be invaluable tools for studying human development in vitro. To understand the mechanisms regulating human skin homeostasis and injury repair at the molecular level, recent efforts aim to differentiate PSCs towards skin epidermal keratinocytes, dermal fibroblasts, and skin appendages such as hair follicles and sebaceous glands. Here, we present an overview of the literature describing strategies for human PSC differentiation towards the components of skin, with a particular focus on keratinocytes. We highlight fundamental advances in the field employing patient-derived human induced PSCs (iPSCs) and skin organoid generation. Importantly, PSCs allow researchers to model inherited skin diseases in the search for potential treatments. Skin differentiation from human PSCs holds the potential to clarify human skin biology.
ABSTRACT
Although Rho regulates cytokinesis, little was known about the functions in mitosis of Cdc42 and Rac. We recently suggested that Cdc42 works in metaphase by regulating bi-orient attachment of spindle microtubules to kinetochores. We now confirm the role of Cdc42 by RNA interference and identify the mechanisms for activation and down-regulation of Cdc42. Using a pull-down assay, we found that the level of GTP-Cdc42 elevates in metaphase, whereas the level of GTP-Rac does not change significantly in mitosis. Overexpression of dominant-negative mutants of Ect2 and MgcRacGAP, a Rho GTPase guanine nucleotide exchange factor and GTPase activating protein, respectively, or depletion of Ect2 by RNA interference suppresses this change of GTP-Cdc42 in mitosis. Depletion of Ect2 also impairs microtubule attachment to kinetochores and causes prometaphase delay and abnormal chromosomal segregation, as does depletion of Cdc42 or expression of the Ect2 and MgcRacGAP mutants. These results suggest that Ect2 and MgcRacGAP regulate the activation and function of Cdc42 in mitosis.
Subject(s)
GTPase-Activating Proteins/physiology , Mitosis/physiology , Proto-Oncogene Proteins/physiology , cdc42 GTP-Binding Protein/physiology , Autoantigens/metabolism , Calcium-Binding Proteins/metabolism , Cell Cycle/drug effects , Cell Cycle/physiology , Cell Cycle Proteins , Centromere Protein A , Chromosomal Proteins, Non-Histone/metabolism , GTPase-Activating Proteins/genetics , GTPase-Activating Proteins/metabolism , HeLa Cells , Humans , Kinetics , Kinetochores/metabolism , Mad2 Proteins , Metaphase/physiology , Microscopy, Fluorescence , Microtubule-Associated Proteins/metabolism , Mutation , Nocodazole/pharmacology , Prometaphase/physiology , Protamine Kinase/metabolism , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , RNA Interference/physiology , RNA, Double-Stranded/genetics , Repressor Proteins , Spindle Apparatus/metabolism , Thymidine/pharmacology , Transfection , Tubulin/metabolism , cdc42 GTP-Binding Protein/metabolism , rac GTP-Binding Proteins/metabolismABSTRACT
During mitosis, the mitotic spindle, a bipolar structure composed of microtubules (MTs) and associated motor proteins, segregates sister chromatids to daughter cells. Initially some MTs emanating from one centrosome attach to the kinetochore at the centromere of one of the duplicated chromosomes. This attachment allows rapid poleward movement of the bound chromosome. Subsequent attachment of the sister kinetochore to MTs growing from the other centrosome results in the bi-orientation of the chromosome, in which interactions between kinetochores and the plus ends of MTs are formed and stabilized. These processes ensure alignment of chromosomes during metaphase and their correct segregation during anaphase. Although many proteins constituting the kinetochore have been identified and extensively studied, the signalling responsible for MT capture and stabilization is unclear. Small GTPases of the Rho family regulate cell morphogenesis by organizing the actin cytoskeleton and regulating MT alignment and stabilization. We now show that one member of this family, Cdc42, and its effector, mDia3, regulate MT attachment to kinetochores.
Subject(s)
Carrier Proteins/metabolism , Kinetochores/metabolism , Microtubules/metabolism , cdc42 GTP-Binding Protein/metabolism , Animals , Carrier Proteins/genetics , Formins , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Guanosine Diphosphate/metabolism , HeLa Cells , Humans , Mice , Mitosis/drug effects , Mutation , NIH 3T3 Cells , Signal Transduction/drug effects , Spindle Apparatus/metabolism , rho GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/metabolismABSTRACT
During G2 phase of cell cycle, centrosomes function as a scaffold for activation of mitotic kinases. Aurora-A is first activated at late G2 phase at the centrosome, facilitates centrosome maturation, and induces activation of cyclin B-Cdk1 at the centrosome for mitotic entry. Although several molecules including HEF1 and PAK are implicated in centrosomal activation of Aurora-A, signaling pathways leading to Aurora-A activation at the centrosome, and hence mitotic commitment in vertebrate cells remains largely unknown. Here, we have used Clostridium difficile toxin B and examined the role of Rho GTPases in G2/M transition of HeLa cells. Inactivation of Rho GTPases by the toxin B treatment delayed by 2 h histone H3 phosphorylation, Cdk1/cyclin B activation, and Aurora-A activation. Furthermore, PAK activation at the centrosome that was already present before the toxin addition was significantly attenuated for 2 h by the addition of toxin B, and HEF1 accumulation at the centrosome that occurred in late G2 phase was also delayed. These results suggest that Rho GTPases function in G2/M transition of mammalian cells by mediating multiple signaling pathways converging to centrosomal activation of Aurora-A.
Subject(s)
Bacterial Proteins/pharmacology , Bacterial Toxins/pharmacology , Centrosome/drug effects , Centrosome/enzymology , G2 Phase/drug effects , Mitosis/drug effects , Protein Serine-Threonine Kinases/metabolism , rho GTP-Binding Proteins/metabolism , ADP Ribose Transferases/pharmacology , Adaptor Proteins, Signal Transducing/metabolism , Amides/pharmacology , Aurora Kinases , Botulinum Toxins/pharmacology , CDC2 Protein Kinase/metabolism , Cyclin B/metabolism , Cytochalasin D/pharmacology , Enzyme Activation/drug effects , HeLa Cells , Histones/metabolism , Humans , Models, Biological , Phosphoproteins/metabolism , Phosphorylation/drug effects , Phosphoserine/metabolism , Protein Transport/drug effects , Pyridines/pharmacology , p21-Activated Kinases/metabolismABSTRACT
During somatic cell reprogramming to induced pluripotent stem cells (iPSCs), fibroblasts undergo dynamic molecular changes, including a mesenchymal-to-epithelial transition (MET) and gain of pluripotency; processes that are influenced by Yamanaka factor stoichiometry. For example, in early reprogramming, high KLF4 levels are correlated with the induction of functionally undefined, transiently expressed MET genes. Here, we identified the cell-surface protein TROP2 as a marker for cells with transient MET induction in the high-KLF4 condition. We observed the emergence of cells expressing the pluripotency marker SSEA-1+ mainly from within the TROP2+ fraction. Using TROP2 as a marker in CRISPR/Cas9-mediated candidate screening of MET genes, we identified the transcription factor OVOL1 as a potential regulator of an alternative epithelial cell fate characterized by the expression of non-iPSC MET genes and low cell proliferation. Our study sheds light on how reprogramming factor stoichiometry alters the spectrum of intermediate cell fates, ultimately influencing reprogramming outcomes.
Subject(s)
Cellular Reprogramming/physiology , DNA-Binding Proteins/metabolism , Induced Pluripotent Stem Cells/metabolism , Induced Pluripotent Stem Cells/physiology , Transcription Factors/metabolism , Animals , Biomarkers/metabolism , CRISPR-Cas Systems/physiology , Cell Adhesion Molecules/metabolism , Cell Proliferation/physiology , Epithelial Cells/metabolism , Epithelial Cells/physiology , Epithelial-Mesenchymal Transition/physiology , Female , Fibroblasts/metabolism , Fibroblasts/physiology , Gene Expression Regulation/physiology , Kruppel-Like Factor 4 , Kruppel-Like Transcription Factors/metabolism , Lewis X Antigen/metabolism , Male , Mice , Mice, Inbred C57BLABSTRACT
Here we used RNA interference and examined possible redundancy amongst Rho GTPases in their mitotic role. Chromosome misalignment is induced significantly in HeLa cells by Cdc42 depletion and not by depletion of either one or all of the other four Cdc42-like GTPases (TC10, TCL, Wrch1 or Wrch2), four Rac-like GTPases or three Rho-like GTPases. Notably, combined depletion of Cdc42 and all of the other four Cdc42-like GTPases significantly enhances chromosomal misalignment. These observations suggest that Cdc42 is the primary GTPase functioning during mitosis but that the other four Cdc42-like GTPases can also assume the mitotic role in its absence.
Subject(s)
Mitosis/physiology , cdc42 GTP-Binding Protein/physiology , Base Sequence , DNA Primers , Fluorescent Antibody Technique , HeLa Cells , Humans , RNA InterferenceABSTRACT
The members of Rho-family GTPases regulate progression through mitosis. Rho induces the contractile ring at the equatorial cortex of the dividing cell, and thus works as a molecular switch between nuclear division and cytokinesis. Cdc42 regulates the progression from prometaphase to metaphase by stabilizing microtubule attachment to the kinetochore. These results suggest that Rho GTPases are activated at specific points in mitosis and regulate each step. Here we describe the methods to analyze the activity and regulation of Rho GTPases during mitosis.
Subject(s)
Mitosis/physiology , rho GTP-Binding Proteins/metabolism , Carrier Proteins/metabolism , Formins , Glutathione Transferase/metabolism , Guanine Nucleotide Exchange Factors/metabolism , HeLa Cells , Humans , Protein Structure, Tertiary , RNA Interference , Recombinant Fusion Proteins/metabolism , cdc42 GTP-Binding Protein/metabolism , rac GTP-Binding Proteins/metabolismABSTRACT
Transgenics is a mainstay of functional genomics. Conditionally overexpressing genes of interest (GOIs) helps to reveal their roles in the control of complex biological processes. Complemented by findings in classic animal model systems, recent advances in human embryonic stem cell (hESC) and patient-specific induced pluripotent stem cell (hiPSC) differentiation have led to sophisticated in vitro models of human development and disease. Yet, as transgenic elements encoding inducible systems must be introduced de novo into each genetically unique human stem cell line, robust and straightforward solutions to gene delivery are required. Transposons are a family of mobile DNA elements that have been adapted as experimental tools for stable genomic integration of transgenes. The piggyBac (PB) transposon from Trichoplusia ni presents a number of benefits over classic viral or BAC transgenesis: ease of application, simple integration-site mapping, and the unique capacity for traceless excision. Moreover, their large capacity permits the consolidation of multiple transgene components in a single vector system. In this chapter, we outline the features of a panel of "All-in-One" PB transposons designed for drug-inducible gene expression and provide guidelines to establish and validate populations or clones of transgenic hiPSCs.
Subject(s)
Cell Culture Techniques/methods , Cellular Reprogramming Techniques/methods , Cellular Reprogramming , DNA Transposable Elements/genetics , Gene Expression/genetics , Genetic Vectors/genetics , Induced Pluripotent Stem Cells/cytology , Transgenes , Cell Separation/methods , Cell Tracking/methods , Cells, Cultured , Clone Cells/cytology , Doxycycline/pharmacology , Fibroblasts/cytology , Gene Expression/drug effects , Genes, Reporter , Green Fluorescent Proteins/genetics , Humans , Induced Pluripotent Stem Cells/metabolism , Luciferases/genetics , Luminescent Proteins/genetics , Neomycin/pharmacology , Puromycin/pharmacology , Transgenes/genetics , Red Fluorescent ProteinABSTRACT
As the quintessential reprogramming model, OCT3/4, SOX2, KLF4, and c-MYC re-wire somatic cells to achieve induced pluripotency. Yet, subtle differences in methodology confound comparative studies of reprogramming mechanisms. Employing transposons, we systematically assessed cellular and molecular hallmarks of mouse somatic cell reprogramming by various polycistronic cassettes. Reprogramming responses varied in the extent of initiation and stabilization of transgene-independent pluripotency. Notably, the cassettes employed one of two KLF4 variants, differing only by nine N-terminal amino acids, which generated dissimilar protein stoichiometry. Extending the shorter variant by nine N-terminal amino acids or augmenting stoichiometry by KLF4 supplementation rescued both protein levels and phenotypic disparities, implicating a threshold in determining reprogramming outcomes. Strikingly, global gene expression patterns elicited by published polycistronic cassettes diverged according to each KLF4 variant. Our data expose a Klf4 reference cDNA variation that alters polycistronic factor stoichiometry, predicts reprogramming hallmarks, and guides comparison of compatible public data sets.
Subject(s)
Cellular Reprogramming/genetics , Kruppel-Like Transcription Factors/genetics , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Protein Interaction Domains and Motifs/genetics , Alternative Splicing , Animals , Cell Differentiation , DNA Transposable Elements , Gene Expression , Gene Expression Regulation , Gene Targeting , Kruppel-Like Factor 4 , Kruppel-Like Transcription Factors/chemistry , Mice , Phenotype , Protein IsoformsABSTRACT
The control of the cell microenvironment on model patterned substrates allows the systematic study of cell biology in well defined conditions, potentially using automated systems. The extreme protein resistance of poly(oligo(ethylene glycol methacrylate)) (POEGMA) brushes is exploited to achieve high fidelity patterning of single cells. These coatings can be patterned by soft lithography on large areas (a microscope slide) and scale (substrates were typically prepared in batches of 200). The present protocol relies on the adsorption of extra-cellular matrix (ECM) proteins on unprotected areas using simple incubation and washing steps. The stability of POEGMA brushes, as examined via ellipsometry and SPR, is found to be excellent, both during storage and cell culture. The impact of substrate treatment, brush thickness and incubation protocol on ECM deposition, both for ultra-thin gold and glass substrates, is investigated via fluorescence microscopy and AFM. Optimised conditions result in high quality ECM patterns at the micron scale, even on glass substrates, that are suitable for controlling cell spreading and polarisation. These patterns are compatible with state-of-the-art technologies (fluorescence microscopy, FRET) used for live cell imaging. This technology, combined with single cell analysis methods, provides a platform for exploring the mechanisms that regulate cell behaviour.
Subject(s)
Cell Adhesion , Cell Polarity , Coated Materials, Biocompatible/metabolism , Methacrylates/metabolism , Polyethylene Glycols/metabolism , 3T3 Cells , Adsorption , Animals , Blood Proteins/metabolism , Cells, Cultured , Coated Materials, Biocompatible/chemistry , Extracellular Matrix Proteins/chemistry , Glass/chemistry , Gold/chemistry , Humans , Keratinocytes/cytology , Methacrylates/chemistry , Mice , Polyethylene Glycols/chemistry , Polymethacrylic Acids , Protein BindingABSTRACT
Cdc42 and Rac family GTPases are important regulators of morphology, motility, and polarity in a variety of mammalian cell types. However, comprehensive analysis of their roles in the morphological and behavioral aspects of chemotaxis within a single experimental system is still lacking. Here we demonstrate using a direct viewing chemotaxis assay that of all of the Cdc42/Rac1-related GTPases expressed in primary fibroblasts, Cdc42, Rac1, and RhoG are required for efficient migration towards platelet-derived growth factor (PDGF). During migration, Cdc42-, Rac1-, and RhoG-deficient cells show aberrant morphology characterized as cell elongation and cell body rounding, loss of lamellipodia, and formation of thick membrane extensions, respectively. Analysis of individual cell trajectories reveals that cell speed is significantly reduced, as well as persistence, but to a smaller degree, while the directional response to the gradient of PDGF is not affected. Combined knockdown of Cdc42, Rac1, and RhoG results in greater inhibition of cell speed than when each protein is knocked down alone, but the cells are still capable of migrating toward PDGF. We conclude that, Cdc42, Rac1, and RhoG function cooperatively during cell migration and that, while each GTPase is implicated in the control of morphology and cell speed, these and other Cdc42/Rac-related GTPases are not essential for the directional response toward PDGF.
Subject(s)
Cell Movement/physiology , Chemotaxis/physiology , Fibroblasts/physiology , Platelet-Derived Growth Factor/metabolism , cdc42 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/metabolism , Animals , Becaplermin , Biological Assay/instrumentation , Biological Assay/methods , Cell Shape , Cells, Cultured , Fibroblasts/cytology , GTP Phosphohydrolases/genetics , GTP Phosphohydrolases/metabolism , Mice , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-sis , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , cdc42 GTP-Binding Protein/genetics , rac GTP-Binding Proteins/genetics , rac GTP-Binding Proteins/metabolism , rac1 GTP-Binding Protein/genetics , rho GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/metabolismABSTRACT
Rho GTPases including Rho, Rac and Cdc42 are involved in cell morphogenesis by inducing specific types of actin cytoskeleton and alignment and stabilization of microtubules. Previous studies suggest that they also regulate cell cycle progression; Rho, Rac and Cdc42 regulate the G(1)-S progression and Rho controls cytokinesis. However, a role of Rho GTPases in nuclear division has not been definitely shown. We have recently found that Cdc42 and its downstream effector mDia3 are involved in bi-orientation and stabilization of spindle microtubules attachment to kinetochores and regulate chromosome alignment and segregation. Here, we discuss how this is coordinated with other events in mitosis, particularly, with the action of Rho in cytokinesis and how attachment of microtubules to kinetochores is achieved and stabilized. We also discuss redundancy of dc42 and Cdc42-related GTPase(s) and potential mechanisms of chromosome instability in cancer.
Subject(s)
Cell Cycle/physiology , Kinetochores/physiology , Microtubules/physiology , Spindle Apparatus/physiology , rho GTP-Binding Proteins/metabolism , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Chromosomal Instability/physiology , Chromosome Segregation/physiology , Formins , Humans , cdc42 GTP-Binding Protein/genetics , cdc42 GTP-Binding Protein/metabolism , rho GTP-Binding Proteins/geneticsABSTRACT
mDia1, a Rho effector, belongs to the Formin family of proteins, which shares the conserved tandem FH1-FH2 unit structure. Formins including mDia1 accelerate actin nucleation while interacting with actin filament fast-growing ends. Here our single-molecule imaging revealed fast directional movement of mDia1 FH1-FH2 for tens of microns in living cells. The movement of mDia1 FH1-FH2 was blocked by actin-perturbing drugs, and the speed of mDia1 FH1-FH2 movement appeared to correlate with actin elongation rates. In vitro, mDia1 FH1-FH2 associated persistently with the growing actin barbed end. mDia1 probably moves processively along the growing end of actin filaments in cells, and Formins may be a molecular motility machinery that is independent from motor proteins.